Skip to main content

Table 1 Patient characteristics

From: Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database

Cancer

Pancreas

Lung

Upper gastrointestinal

Lower gastrointestinal

Breast

Age, mean (± SD) median [1st and 3rd quartiles], years

 All cancer patients, at inclusion hospital stay (n = 340,946)

69.7 (± 12.0)

66.5 (± 10.9)

68.3 (± 12.5)

68.5 (± 12.3)

61.1 (± 13.6)

70 [62–78]

66 [59–74]

68 [60–78]

69 [61–77]

61 [51–71]

 Cancer patients with a hospitalized VTE, at index hospital stay (n = 24,433)

68.7 (± 11.2)

65.5 (± 10.9)

68.2 (± 12.3)

70.4 (± 12.1)

65.6 (± 13.8)

69 [62–77]

65 [58–73]

69 [60–77]

71 [63–80]

66 [56–76]

Sex, female (%)

 All cancer patients (n = 340,946)

10,841 (49%)

23,951 (32%)

6,630 (29%)

46,431 (44%)

115,540 (99%)

 Cancer patients with a hospitalized VTE (n = 24,433)

1,592 (49%)

2,848 (34%)

650 (29%)

3,114 (44%)

3,545 (98%)

Time between first cancer-related hospital staya and index VTE hospital stay, mean (± SD) median [1st and 3rd quartiles], months

 Cancer patients with a hospitalized VTE (n = 24,433)

8.7 (± 12.9)

10.9 (± 15.3)

10.6 (± 14.3)

14.7 (± 18.8)

21.1 (± 21.5)

3.4 [0–12.9]

4.6 [0.1–16.2]

5.3 [1.1–15.3]

7.2 [0.9–21.2]

14.7 [3.3–33.9]

Cancer status, activeb (%)

 All cancer patients, at inclusion hospital stay (n = 340,946)

14,926 (67%)

46,803 (63%)

14,305 (63%)

48,793 (47%)

61,948 (53%)

 Cancer patients with a hospitalized VTE, at index hospital stay (n = 24,433)

2,023 (62%)

5,930 (71%)

1,451 (65%)

4,446 (63%)

2,584 (72%)

Presence of metastases, yes (%)

 All cancer patients, at inclusion hospital stay (n = 340,946)

7,838 (35%)

31,198 (42%)

8,578 (38%)

36,891 (35%)

41,042 (35%)

 Cancer patients with a hospitalized VTE, at index hospital stay (n = 24,433)

1,279 (40%)

4,374 (52%)

1,081 (48%)

3,537 (50%)

2,036 (56%)

Clinical events during the three months prior to the hospitalized VTE (n = 24,433)

 Infectionsc

432 (13%)

1214 (15%)

333 (15%)

693 (10%)

319 (9%)

 Surgery

280 (9%)

899 (11%)

308 (14%)

1214 (17%)

555 (15%)

 Trauma

54 (2%)

199 (2%)

36 (2%)

157 (2%)

77 (2%)

 Respiratory failure

48 (1%)

361 (4%)

72 (3%)

81 (1%)

52 (1%)

 Heart failure

14 (< 1%)

57 (1%)

6 (< 1%)

30 (< 1%)

16 (< 1%)

 Stroke

12 (< 1%)

66 (1%)

6 (< 1%)

13 (< 1%)

8 (< 1%)

  1. VTE venous thromboembolism, SD standard deviation
  2. aFirst cancer-related hospital stay: first cancer-related hospital stay within five years prior to the 2016 inclusion cancer-related hospital stay
  3. bActive cancer: presence of an ICD-10 code indicative of metastases during the two-year follow-up period, or a chemotherapy within the six months prior to the VTE event
  4. cInfections requiring hospitalization and occurring during a hospital stay